ClassID:

109145

C12N2310/14 - page 8 - CPC Classification

Classification description:

Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.

Recent Application in this class:
#2101
20220133636
2022-05-05

CATIONIC LIPIDS CONTAINING SILICON

#2102
20220127619
2022-04-28

Modulatory polynucleotides

#2103
20220127618
2022-04-28

KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#2104
20220127617
2022-04-28

TREATMENT OF CNS INJURY WITH RNAi THERAPEUTICS

#2105
20220127615
2022-04-28

CORONAVIRUS IRNA COMPOSITIONS AND METHODS OF USE THEREOF

#2106
20220127614
2022-04-28

Compositions and methods for treating COVID-19

#2107
20220127586
2022-04-28

CGAS/DNCV-LIKE NUCLEOTIDYLTRANSFERASES AND USES THEREOF

#2108
20220127580
2022-04-28

COMPOSITIONS AND METHODS FOR REPROGRAMING NON-HEPATOCYTE CELLS INTO HEPATOCYTE CELLS

#2109
20220125823
2022-04-28

EXTRAHEPATIC DELIVERY

#2110
20220125822
2022-04-28

Treatment methods for fibrosis targeting SMOC2

#2111
20220125768
2022-04-28

Targeting RNA viruses using inhibitors of METTL3

#2112
20220119838
2022-04-21

Compositions and methods for regulating production of a fusion protein and ribonucleic acid

#2113
20220119824
2022-04-21

IMMUNOSTIMULATORY BACTERIA-BASED VACCINES, THERAPEUTICS, AND RNA DELIVERY PLATFORMS

#2114
20220119817
2022-04-21

Polycomb-associated Non-Coding RNAs

#2115
20220119815
2022-04-21

ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

#2116
20220119814
2022-04-21

Therapeutic alteration of transplantable tissues through or exposure to RNA interference molecules

#2117
20220119439
2022-04-21

5'-Cyclo-Phosphonate Modified Nucleotides

#2118
20220117999
2022-04-21

PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#2119
20220113311
2022-04-14

Methods of Detecting and Treating a Tumor Expressing PT346 PDK1

#2120
20220112521
2022-04-14

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

#2121
20220112505
2022-04-14

RNAi Inhibition of Alpha-ENaC Expression

#2122
20220112501
2022-04-14

Engineered immunostimulatory bacterial strains and uses thereof

#2123
20220112492
2022-04-14

COMPOSITIONS AND METHODS FOR INDUCED TISSUE REGENERATION IN MAMMALIAN SPECIES

#2124
20220112281
2022-04-14

METHODS FOR REDUCING POST-OPERATIVE COGNITIVE DYSFUNCTION (POCD)

#2125
20220111073
2022-04-14

Nanoparticles comprising protein-polynucleotide complexes and for delivering protein based complexes

#2126
20220107246
2022-04-07

NONCOVALENT TAGS AND RELATED METHODS FOR CYTOSOLIC DELIVERY OF MACROBIOMOLECULES

#2127
20220106598
2022-04-07

HOMOLOGOUS RECOMBINATION DIRECTED GENOME EDITING IN EUKARYOTES

#2128
20220106597
2022-04-07

Methods For Preventing Titration Of Bimolecular Templated Assembly Reactions By Structurally-Determined Differential Hybridizations

#2129
20220106596
2022-04-07

A METHOD OF GENE EDITING

#2130
20220106593
2022-04-07

Multi-targeted single entity conjugates

#2131
20220106388
2022-04-07

HIGH VISCOSITY MACROMOLECULAR COMPOSITIONS FOR TREATING OCULAR CONDITIONS

#2132
20220105192
2022-04-07

COMPOSITION, METHOD AND USE THEREOF

#2133
20220098615
2022-03-31

DUAL FUNCTIONAL EXPRESSION VECTORS AND METHODS OF USE THEREOF

#2134
20220098613
2022-03-31

REDUCING CD33 EXPRESSION TO SELECTIVELY PROTECT THERAPEUTIC CELLS

#2135
20220098589
2022-03-31

COMPOSITION FOR DELIVERY OF GENETIC MATERIAL

#2136
20220098585
2022-03-31

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

#2137
20220098327
2022-03-31

COMPOSITIONS AND METHODS COMPRISING HISTIDYL-TRNA SYNTHETASE SPLICE VARIANTS HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES

#2138
20220098142
2022-03-31

CATIONIC LIPID

#2139
20220096647
2022-03-31

COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY

#2140
20220096527
2022-03-31

PAPD5 AND PAPD7 INHIBITORS FOR TREATING A HEPATITIS B INFECTION

#2141
20220090088
2022-03-24

Targeted Nuclear RNA Cleavage and Polyadenylation with CRISPR-Cas

#2142
20220090086
2022-03-24

IDENTIFICATION OF MOLECULAR PATHWAYS AND METHODS OF USE THEREOF FOR TREATING RETINAL NEURODEGENERATION AND OTHER NEURODEGENERATIVE DISORDERS

#2143
20220090085
2022-03-24

Compositions and methods for reactivating latent immunodeficiency virus

#2144
20220090079
2022-03-24

Methods and compositions for managing vascular conditions using miR-483 mimics and HIF1alpha pathway inhibitors

#2145
20220090078
2022-03-24

COMPOSITIONS AND METHODS FOR INDUCED TISSUE REGENERATION IN MAMMALIAN SPECIES

#2146
20220090077
2022-03-24

RNAi Agents for Inhibiting Expression of Alpha-ENaC And Methods of Use

#2147
20220090074
2022-03-24

HNF4a saRNA compositions and methods of use

#2148
20220090072
2022-03-24

Method of treating fatty liver disease

#2149
20220090070
2022-03-24

METHODS AND COMPOSITIONS FOR ALTERING FUNCTION AND STRUCTURE OF CHROMATIN LOOPS AND/OR DOMAINS

#2150
20220090068
2022-03-24

Complement component C5 iRNA compositions and methods of use thereof

#2151
20220090067
2022-03-24

Products and compositions

#2152
20220090066
2022-03-24

CELL PENETRATING MOLECULE

#2153
20220087531
2022-03-24

RNA INTERFERENCE COMPOSITIONS AND METHODS FOR MALIGNANT TUMORS

#2154
20220081695
2022-03-17

COMPOSITIONS AND METHODS FOR CONTROLLING INSECT PESTS

#2155
20220081691
2022-03-17

MODULATING PTPN2 TO INCREASE IMMUNE RESPONSES AND PERTURBING GENE EXPRESSION IN HEMATOPOIETIC STEM CELL LINEAGES

#2156
20220079973
2022-03-17

RNAi agents for Hepatitis B virus infection

#2157
20220079971
2022-03-17

SERPINC1 iRNA Compositions and Methods of Use Thereof

#2158
20220074925
2022-03-10

SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS

#2159
20220073929
2022-03-10

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#2160
20220073928
2022-03-10

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#2161
20220073927
2022-03-10

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#2162
20220073926
2022-03-10

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#2163
20220073925
2022-03-10

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#2164
20220073924
2022-03-10

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

#2165
20220073923
2022-03-10

METHODS AND COMPOSITIONS USING RNA INTERFERENCE AND ANTISENSE OLIGONUCLEOTIDES FOR INHIBITION OF KRAS

#2166
20220073918
2022-03-10

Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAs targeting the expanded hexanucleotide repeat

#2167
20220073647
2022-03-10

APPLICATION OF PCSK9 INHIBITORS IN THE PREPARATION OF DRUGS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNE DISEASES

#2168
20220072027
2022-03-10

Pharmaceutical composition for preventing or treating liver cancer

#2169
20220072024
2022-03-10

COMPOSITIONS AND METHODS FOR INHIBITING HMGB1 EXPRESSION

#2170
20220065859
2022-03-03

Application of ERH gene in the preparation of bladder cancer diagnosis and treatment products

#2171
20220064732
2022-03-03

METHODS FOR TREATING PARKINSON'S DISEASE

#2172
20220064645
2022-03-03

Double-stranded RNA molecule targeting CKIP-1 and use thereof

#2173
20220064641
2022-03-03

RECOMBINANT VIRUS PRODUCTS AND METHODS FOR INHIBITION OF EXPRESSION OF MYOTILIN

#2174
20220064640
2022-03-03

DOUBLE-STRANDED NUCLEIC ACID INHIBITOR MOLECULES CONTAINING A TRILOOP

#2175
20220064639
2022-03-03

Compounds and methods for reducing ATXN2 expression

#2176
20220062434
2022-03-03

Compositions and methods of treating muscle atrophy and myotonic dystrophy

#2177
20220062427
2022-03-03

NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING NUCLEIC ACID, PREPARATION METHOD THEREFOR AND USE THEREOF

#2178
20220062286
2022-03-03

USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER

#2179
20220061335
2022-03-03

CONTROL OF INSECT INFESTATION

#2180
20220057404
2022-02-24

METHODS OF DETECTING AND REDUCING CANCER CELL CENTRAL NERVOUS SYSTEM COLONIZATION

#2181
20220056456
2022-02-24

MEANS AND METHODS FOR REDUCING TUMORIGENICITY OF CANCER STEM CELLS

#2182
20220056454
2022-02-24

RNAi Agents for Inhibiting Expression of 17beta-HSD Type 13 (HSD17B13), Compositions Thereof, and Methods of Use

#2183
20220056448
2022-02-24

Modified double-stranded RNA agents

#2184
20220056444
2022-02-24

PROCESS TO INHIBIT OR ELIMINATE EOSINOPHILIC DISEASES OF THE AIRWAY AND RELATED CONDITIONS

#2185
20220056441
2022-02-24

RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (SINA)

#2186
20220049276
2022-02-17

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#2187
20220049256
2022-02-17

CONTROL OF PLANT PESTS USING RNA MOLECULES

#2188
20220049253
2022-02-17

COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF APOLIPOPROTEIN C-III (APOC3) GENES

#2189
20220049252
2022-02-17

CHEMICALLY-MODIFIED RNAi CONSTRUCTS AND USES THEREOF

#2190
20220049249
2022-02-17

Double-stranded oligonucleotide, composition and conjugate comprising double-stranded oligonucleotide, preparation method thereof and use thereof

#2191
20220048979
2022-02-17

Treatment of staphylococcal disorders

#2192
20220047728
2022-02-17

RNA nanoparticles and method of use thereof

#2193
20220042101
2022-02-10

Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors

#2194
20220042023
2022-02-10

Genetic and pharmacological transcriptional upregulation of the repressed FXN gene as a therapeutic strategy for Friedreich ataxia

#2195
20220042021
2022-02-10

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

#2196
20220042020
2022-02-10

PHARMACEUTICAL COMPOSITION THAT INHIBITS PRODUCTION OF HEPATITIS B VIRUS PROTEIN AND SCREENING METHOD

#2197
20220042012
2022-02-10

INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#2198
20220041987
2022-02-10

Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

#2199
20220040333
2022-02-10

Use of neuroglobin agonist for preventing or treating mitochondrial RCCI and/or RCCIII deficiency disease

#2200
20220040323
2022-02-10

Compositions and methods of treating muscle atrophy and myotonic dystrophy

#2201
20220040322
2022-02-10

Compositions and methods of treating muscle atrophy and myotonic dystrophy

#2202
20220040308
2022-02-10

LIPID COMPOSITIONS

#2203
20220040276
2022-02-10

Compositions and methods for delivery of biomacromolecule agents

#2204
20220040220
2022-02-10

Treatment of thymic stromal lymphopoietin (TSLP) related diseases by inhibition of long-form TSLP transcripts

#2205
20220033826
2022-02-03

ADENO-ASSOCIATED VIRAL VECTORS FOR THE TREATMENT OF BEST DISEASE

#2206
20220033817
2022-02-03

Targeting Ligands

#2207
20220033502
2022-02-03

Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents

#2208
20220031865
2022-02-03

COMBINATION THERAPY FOR TREATING MUSCULAR DYSTROPHY

#2209
20220026444
2022-01-27

Methods for diagnosing and/or treating acute or chronic liver, kidney or lung disease

#2210
20220025407
2022-01-27

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#2211
20220025379
2022-01-27

METHODS OF TREATING SCHIZOPHRENIA AND OTHER NEUROPSYCHIATRIC DISORDERS

#2212
20220025374
2022-01-27

Methods for preventing graft ischemia reperfusion injury during ex vivo machine perfusion preservation

#2213
20220025367
2022-01-27

NOVEL RNA COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL8

#2214
20220025366
2022-01-27

Compounds and methods for reducing prion expression

#2215
20220025053
2022-01-27

Methods of Inhibiting Metastasis in Cancer

#2216
20220024975
2022-01-27

Alpha-v beta-6 integrin ligands and uses thereof

#2217
20220024887
2022-01-27

Ubiquitin-specific peptidase 24 inhibitor, medicinal composition including the same and method of delaying or reversing multidrug resistance in cancers using the same

#2218
20220023429
2022-01-27

CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

#2219
20220023427
2022-01-27

Lipids and compositions for the delivery of therapeutics

#2220
20220017971
2022-01-20

COMPOSITION FOR PREDICTING CHEMOTHERAPY RESISTANCE OF OVARIAN CANCER AND USE THEREOF

#2221
20220017914
2022-01-20

RNAI STRATEGIES FOR CONTROL OF WHITEFLY

#2222
20220017906
2022-01-20

RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF

#2223
20220017905
2022-01-20

METHODS FOR IDENTIFYING THERAPEUTIC TARGETS AND TREATING AND MONITORING CANCERS

#2224
20220017904
2022-01-20

ENGINEERED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF

#2225
20220017903
2022-01-20

Compositions and methods for treatment of Friedreich's Ataxia

#2226
20220017902
2022-01-20

METHODS AND COMPOSITIONS FOR TREATING A SERPINC1-ASSOCIATED DISORDER

#2227
20220017900
2022-01-20

METHODS OF CANCER TREATMENT

#2228
20220017899
2022-01-20

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF C3 IN A CELL

#2229
20220010338
2022-01-13

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#2230
20220010323
2022-01-13

METHOD TO OBTAIN LOW TRITERPENE/TRITERPENOID-CONTAINING NATURAL RUBBER LATEX

#2231
20220010314
2022-01-13

RNAI INDUCED REDUCTION OF ATAXIN-3 FOR THE TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 3

#2232
20220010308
2022-01-13

COMPOSITIONS AND METHODS FOR CONTROLLING ARTHROPOD PARASITE AND PEST INFESTATIONS

#2233
20220010300
2022-01-13

METHODS OF TREATING NEURODEGENERATIVE DISORDERS AND IDENTIFYING TARGETS THEREFORE

#2234
20220010272
2022-01-13

Cell line with METTL3 gene knocked out, its construction method and interference vector

#2235
20220008550
2022-01-13

Compositions and methods of treating muscle atrophy and myotonic dystrophy

#2236
20220002816
2022-01-06

IDENTIFICATION OF JUND TARGET GENES FOR INHIBITION OF PROSTATE CANCER CELL GROWTH

#2237
20220002732
2022-01-06

INHIBIN AS TARGETABLE REGULATORS OF ANGIOGENESIS

#2238
20220002731
2022-01-06

Oligonucleotides for treatment of angiopoietin like 4 (ANGPTL4) related diseases

#2239
20220002727
2022-01-06

MODIFIED DOUBLE-STRANDED RNA AGENTS

#2240
20220002722
2022-01-06

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL

#2241
20220002721
2022-01-06

Antisense RNA targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A disease

#2242
20220002720
2022-01-06

COMPOSITIONS AND METHODS FOR CONTROLLING ARTHORPOD PARASITE AND PEST INFESTATIONS

#2243
20220002502
2022-01-06

Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation

#2244
20220002416
2022-01-06

COMPOSITIONS AND METHODS FOR MODULATING CANCER IMMUNE FITNESS

#2245
20220002400
2022-01-06

Methods of Treating Influenza A Virus Infections

#2246
20220000817
2022-01-06

PROGNOSIS AND TREATMENT OF METASTATIC CANCER

#2247
20220000778
2022-01-06

Lipid nanoparticle formulations

#2248
20220000123
2022-01-06

CONTROL OF COLEOPTERAN INSECTS

#2249
20210403987
2021-12-30

Methods and compositions for determining pH

#2250
20210403949
2021-12-30

Vector system for expressing regulatory RNA

#2251
20210403939
2021-12-30

COPI COATOMER GAMMA SUBUNIT NUCLEIC ACID MOLECULES THAT CONFER RESISTANCE TO COLEOPTERAN AND HEMIPTERAN PESTS

#2252
20210403917
2021-12-30

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE

#2253
20210403915
2021-12-30

Genetically modified mesenchymal stem cells for use in cardiovascular prosthetics

#2254
20210403914
2021-12-30

Specific siRNA molecules, composition and use thereof for the treatment of triple negative breast cancer

#2255
20210403912
2021-12-30

COMPOSITIONS AND METHODS FOR CONTROLLING INSECT PESTS

#2256
20210403911
2021-12-30

Control of insect infestation

#2257
20210403909
2021-12-30

Extended dicer substrate agents and methods for the specific inhibition of gene expression

#2258
20210403908
2021-12-30

COMPOSITIONS AND METHODS FOR TREATMENT OF HEPATITIS D VIRUS INFECTION

#2259
20210403866
2021-12-30

ENHANCED DENDRITIC CELL IMMUNE ACTIVATION BY COMBINED INHIBITION OF NR2F6 WITH CANNIBIDIOL

#2260
20210402007
2021-12-30

POLYNUCLEOTIDE AGENTS TARGETING HYDROXYACID OXIDASE (GLYCOLATE OXIDASE, HAO1) AND METHODS OF USE THEREOF

#2261
20210401994
2021-12-30

SiRNA conjugate, preparation method therefor and use thereof

#2262
20210401868
2021-12-30

Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules

#2263
20210400988
2021-12-30

COMPOSITIONS AND METHODS FOR MODULATING EGG DEVELOPMENT IN MOSQUITOES

#2264
20210395752
2021-12-23

VDAC1 SILENCING MOLECULES AND USE THEREOF

#2265
20210395748
2021-12-23

Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors

#2266
20210395745
2021-12-23

RNAI AGENTS FOR HEPATITIS B VIRUS INFECTION

#2267
20210395744
2021-12-23

COMPOSITIONS AND METHODS FOR TREATING COVID-19

#2268
20210395738
2021-12-23

CONTROL OF INSECT INFESTATION

#2269
20210395733
2021-12-23

Monocarboxylate transporter (MCT) antisense oligonucleotide (ASO) inhibitors for use as therapeutics in the treatment of cancer

#2270
20210395731
2021-12-23

Method and composition for inhibiting growth of bacterium

#2271
20210395725
2021-12-23

Target-specific extracellular vesicles

#2272
20210395721
2021-12-23

METHODS TO IMPROVE POTENCY OF ELECTROPORATION

#2273
20210395699
2021-12-23

Compositions and methods for differentiation of human pluripotent stem cells into desired cell types

#2274
20210395192
2021-12-23

Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids

#2275
20210393934
2021-12-23

MEDICAL DEVICES FOR DELIVERY OF siRNA

#2276
20210388444
2021-12-16

FUS/TLS-BASED COMPOUNDS AND METHODS FOR DIAGNOSIS, TREATMENT AND PREVENTION OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED MOTOR NEURON DISEASES

#2277
20210388395
2021-12-16

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#2278
20210388394
2021-12-16

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#2279
20210388360
2021-12-16

COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF PROTEIN C (PROC) GENES

#2280
20210388358
2021-12-16

Extended dicer substrate agents and methods for the specific inhibition of gene expression

#2281
20210388355
2021-12-16

Dosages and methods for delivering lipid formulated nucleic acid molecules

#2282
20210388349
2021-12-16

Gene-regulating compositions and methods for improved immunotherapy

#2283
20210388322
2021-12-16

METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS USING RNA NANOPARTICLES FOR CELL TRANSFORMATION

#2284
20210388196
2021-12-16

GENE DELIVERY CARRIER

#2285
20210388039
2021-12-16

BT TOXIN RECEPTORS AND METHODS OF USE

#2286
20210381005
2021-12-09

Temperature-based transient delivery of nucleic acids and proteins to cells and tissues

#2287
20210380988
2021-12-09

Reducing Prominin2-Mediated Resistance to Ferroptotic Cell Death

#2288
20210380985
2021-12-09

17ß-Hydroxysteroid Dehydrogenase Type 13 (HSD17B13) iRNA Compositions And Methods Of Use Thereof

#2289
20210380984
2021-12-09

Compositions and methods for inhibiting ALDH2 expression

#2290
20210380979
2021-12-09

MULTIMERIC OLIGONUCLEOTIDES HAVING DECREASED KIDNEY CLEARANCE

#2291
20210380978
2021-12-09

The long non-coding RNA INCA1 and Homo sapiens heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1) as therapeutic targets for immunotherapy

#2292
20210380977
2021-12-09

Myocardial enhancer RNA and methods of use

#2293
20210380712
2021-12-09

Targeting metastasis stem cells through a fatty acid receptor (CD36)

#2294
20210380690
2021-12-09

Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

#2295
20210379105
2021-12-09

GENE EDITING OF MONOGENIC DISORDERS IN HUMAN HEMATOPOIETIC STEM CELLS -- CORRECTION OF X-LINKED AGAMMAGLOBULINEMIA (XLA)

#2296
20210371855
2021-12-02

METHODS OF INHIBITING PROLIFERATIVE CELLS

#2297
20210371470
2021-12-02

COMPOSITIONS AND METHODS FOR DELIVERY OF AAV

#2298
20210369869
2021-12-02

NUCLEIC ACID MOLECULES CONTAINING SPACERS AND METHODS OF USE THEREOF

#2299
20210369866
2021-12-02

Biodegradable lipids for delivery of nucleic acids

#2300
20210369863
2021-12-02

Method of delivering genes and drugs to a posterior segment of an eye

#2301
20210369762
2021-12-02

Compositions and methods of treating Facioscapulohumeral muscular dystrophy

#2302
20210369761
2021-12-02

METHODS OF TREATING MOTOR NEURON DISEASES

#2303
20210363529
2021-11-25

RNAi nano-preparation, preparation method thereof and application thereof in TMV prevention and control

#2304
20210363526
2021-11-25

Use of Non-Coding Nucleic Acid for Crop Improvement and Protection Against Microbes

#2305
20210363525
2021-11-25

SARNA COMPOSITIONS AND METHODS OF USE

#2306
20210363523
2021-11-25

OLIGONUCLEOTIDES FOR MAPT MODULATION

#2307
20210363192
2021-11-25

ENGINEERED AAV CAPSIDS WITH INCREASED TROPISM AND AAV VECTORS COMPRISING THE ENGINEERED CAPSIDS AND METHODS OF MAKING AND USING SAME

#2308
20210361694
2021-11-25

METHOD FOR PREVENTING OR TREATING CANCER USING SYT11 INHIBITOR

#2309
20210361692
2021-11-25

Compositions and methods for treating transthyretin (TTR) mediated amyloidosis

#2310
20210355509
2021-11-18

ALTERNATIVE SPLICING REGULATION OF GENE EXPRESSION AND THERAPEUTIC METHODS

#2311
20210355491
2021-11-18

OLIGONUCLEOTIDES FOR MSH3 MODULATION

#2312
20210355210
2021-11-18

Therapeutic and diagnostic methods relating to cancer stem cells

#2313
20210353721
2021-11-18

METHODS AND COMPOSITIONS RELATING TO INHIBITING CARDIOVASCULAR CALCIFICATION VIA ANNEXIN A1

#2314
20210353620
2021-11-18

Method of treating severe acute respiratory syndrome (SARS) virus infection by administering a protein disulfide isomerase (PDI) inhibitor

#2315
20210348171
2021-11-11

PHARMACOPROTEOMICS PLATFORM IDENTIFYING KINOME FEATURES REGULATING DRUG RESPONSE IN CANCER

#2316
20210348170
2021-11-11

Compositions and methods for treating beta-hemoglobinopathies

#2317
20210348169
2021-11-11

Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1

#2318
20210348167
2021-11-11

siNA MOLECULES, METHODS OF PRODUCTION AND USES THEREOF

#2319
20210348166
2021-11-11

IMMUNOTHERAPY OF CANCER

#2320
20210348162
2021-11-11

Compositions and methods for inhibiting expression of the LECT2 gene

#2321
20210347887
2021-11-11

COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE

#2322
20210340575
2021-11-04

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#2323
20210340547
2021-11-04

Fibrotic treatment

#2324
20210340545
2021-11-04

METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF RESPIRATORY INFECTIONS

#2325
20210340541
2021-11-04

METHODS AND COMPOSITIONS TO INHIBIT METASTASIS AND TO TREAT FIBROSIS AND TO ENHANCE WOUND HEALING

#2326
20210340533
2021-11-04

Oligonucleotides for tissue specific gene expression modulation

#2327
20210340235
2021-11-04

Use of regulatory T cell-specific surface protein LRIG-1

#2328
20210338723
2021-11-04

COMPOSITIONS AND METHODS FOR INHIBITING OR SCREENING FOR CD8 AND METHODS AND ASSAYS FOR DETECTING CD8 IN CELLS

#2329
20210338584
2021-11-04

Method for preparing liposomes

#2330
20210332391
2021-10-28

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#2331
20210332390
2021-10-28

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#2332
20210332385
2021-10-28

GENE THERAPIES FOR LYSOSOMAL DISORDERS

#2333
20210332369
2021-10-28

USE OF CBX4 AS TARGET FOR ACTIVATION OF HIV-1 LATENT INFECTION

#2334
20210332367
2021-10-28

KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#2335
20210332358
2021-10-28

MINIATURIZED HAIRPIN RNAi TRIGGERS (mxRNA) AND METHODS OF USES THEREOF

#2336
20210330810
2021-10-28

Compositions containing nucleic acid nanoparticles with modular functionality

#2337
20210330783
2021-10-28

HIV pre-immunization and immunotherapy

#2338
20210330692
2021-10-28

CCR7 aptamers and uses thereof

#2339
20210324419
2021-10-21

Delivery across cell plasma membranes

#2340
20210324414
2021-10-21

COMPOSITIONS AND METHODS FOR SEQUESTERING VIRUSES

#2341
20210324406
2021-10-21

Methods and compositions for nucleic acid and protein payload delivery

#2342
20210324390
2021-10-21

METHODS FOR IMPROVING PRODUCTION OF BIOLOGICAL PRODUCTS BY REDUCING THE LEVEL OF ENDOGENOUS PROTEIN

#2343
20210324387
2021-10-21

AAV VECTORS FOR TREATMENT OF DOMINANT RETINITIS PIGMENTOSA

#2344
20210324384
2021-10-21

SILENCING TGF-BETA 1 and COX2 USING siRNAs DELIVERED in a POLYPEPTIDE NANOPARTICLE ALONE and in COMBINATION with IMMUNE CHECKPOINT INHIBITORS to TREAT CANCER

#2345
20210324101
2021-10-21

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING HYPERTROPHIC CARDIOMYOPATHY

#2346
20210324023
2021-10-21

MODULATING IMMUNE RESPONSES

#2347
20210323984
2021-10-21

Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells

#2348
20210322563
2021-10-21

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

#2349
20210322455
2021-10-21

METHODS AND COMPOSITIONS FOR INCREASING THE SUPPRESSIVE FUNCTION OF REGULATORY T-CELLS (TREGS)

#2350
20210322422
2021-10-21

USE OF AKT INHIBITORS IN OPHTHALMOLOGY

#2351
20210322330
2021-10-21

siRNA nanocapsule and preparation method and use thereof

#2352
20210317461
2021-10-14

OLIGONUCLEOTIDE COMPOSITIONS FOR TARGETING CCR2 AND CSF1R AND USES THEREOF

#2353
20210317460
2021-10-14

Oligonucleotides for PRNP modulation

#2354
20210317452
2021-10-14

SERPINA1 iRNA compositions and methods of use thereof

#2355
20210317186
2021-10-14

Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) protein

#2356
20210317180
2021-10-14

NR2F6 INHIBITED CHIMERIC ANTIGEN RECEPTOR CELLS

#2357
20210315996
2021-10-14

PKC INHIBITORS FOR THE TREATMENT OF SEPTIC CHOLESTASIS WITH POLYMETHINE DYE TARGETING

#2358
20210311062
2021-10-07

Method for diagnosis, prognosis and determination of treatment for cutaneous t-cell lymphoma

#2359
20210310006
2021-10-07

Angiotensinogen (AGT) iRNA compositions and methods of use thereof

#2360
20210309999
2021-10-07

VARIANT RNAi AGAINST ALPHA-SYNUCLEIN

#2361
20210309998
2021-10-07

Therapeutic and diagnostic target for SARS-CoV-2 and COVID-19

#2362
20210309620
2021-10-07

Substituted imidazoles for preventing and/or treating cell or tissue necrosis

#2363
20210308274
2021-10-07

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FRIEDREICH'S ATAXIA

#2364
20210308106
2021-10-07

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SYSTEMIC MASTOCYTOSIS

#2365
20210308069
2021-10-07

Preparation and use of sugar-targeting nanoparticles for modifying SiRNA

#2366
20210301294
2021-09-30

RNAi agents for inhibiting expression of PNPLA3, pharmaceutical compositions thereof, and methods of use

#2367
20210301292
2021-09-30

Compositions of Asymmetric Interfering RNA and Uses Thereof

#2368
20210301290
2021-09-30

Compositions and methods of treating Facioscapulohumeral muscular dystrophy

#2369
20210301287
2021-09-30

Treatment Of Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, And Liver Fibrosis

#2370
20210301280
2021-09-30

Ligase mutant

#2371
20210299266
2021-09-30

Compositions and methods of treating muscle dystrophy

#2372
20210299105
2021-09-30

Selective inhibition of T Follicular Helper cells for treatment of autoimmune disorders

#2373
20210299078
2021-09-30

Inducing proliferation of cardiomyocytes and therapeutic uses related thereto

#2374
20210299074
2021-09-30

COMPOSITIONS AND METHODS FOR REGULATING BODY WEIGHT AND METABOLIC SYNDROMES

#2375
20210299073
2021-09-30

Compositions and methods for regulating body weight and metabolic syndromes

#2376
20210299060
2021-09-30

CO-DELIVERY OF NUCLEIC ACIDS FOR SIMULTANEOUS SUPPRESSION AND EXPRESSION OF TARGET GENES

#2377
20210292768
2021-09-23

COMPOSITIONS AND AGENTS AGAINST NONALCOHOLIC STEATOHEPATITIS

#2378
20210292766
2021-09-23

Inhibition of protein kinases to treat Friedreich ataxia

#2379
20210292761
2021-09-23

COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF

#2380
20210292758
2021-09-23

Exosomes and miRNA to treat glaucoma

#2381
20210292757
2021-09-23

Extended dicer substrate agents and methods for the specific inhibition of gene expression

#2382
20210292411
2021-09-23

METHOD OF TREATING CANCER

#2383
20210292364
2021-09-23

Peptides for use as cell-penetrating peptides

#2384
20210292303
2021-09-23

AMINE CATIONIC LIPIDS AND USES THEREOF

#2385
20210290773
2021-09-23

Peptidic blocks for nucleic acid delivery

#2386
20210290612
2021-09-23

Methods of treating PACS1 and PACS2 syndromes

#2387
20210290595
2021-09-23

GFI1 INHIBITORS FOR THE TREATMENT OF HYPERGLYCEMIA

#2388
20210290556
2021-09-23

METHODS OF SUPPRESSING DELIVERY OF EXOSOMES TO LIVER AND SPLEEN

#2389
20210285050
2021-09-16

PDE3B VARIANTS

#2390
20210285001
2021-09-16

Long double-stranded RNA for RNA interference

#2391
20210285000
2021-09-16

COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTION

#2392
20210284998
2021-09-16

Compositions for Transfecting Resistant Cell Types

#2393
20210284708
2021-09-16

METHODS OF PROMOTING CNS NEURONAL REPAIR BY INHIBITING LRP-1

#2394
20210283211
2021-09-16

COMPOSITIONS AND METHODS OF ALLEVIATING RESISTANCE TO CHEMOTHERAPY

#2395
20210283134
2021-09-16

Methods of treating cholangiocarcinoma

#2396
20210278420
2021-09-09

Methods and compositions for treating asthma and allergic diseases

#2397
20210277418
2021-09-09

AAV VARIANTS WITH ENHANCED TROPISM

#2398
20210277403
2021-09-09

Methods and compositions for targeting PD-L1

#2399
20210277402
2021-09-09

Targeting microRNA-101-3p in cancer therapy

#2400
20210277400
2021-09-09

Nucleic acid, composition and conjugate comprising the same, and preparation method and use thereof